Entrada Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Entrada Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Entrada Therapeutics Inc
Rating: 2.42975
Author: Trendlyne DVM scores

about

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's E...

11.15 0.15 (1.36%)

126.17% Gain from 52W Low

320.0K

XNAS Volume

XNAS 28 Jan, 2026 4:30 PM (EST)

Not Eligible

Expensive Valuation

21.5 / 100

Technically Bullish

75.7 / 100

1Yr Price target upside is 61%

3 analysts

Entrada Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Entrada Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's E...

126.17% Gain from 52W Low

SWOT Analysis

Entrada Therapeutics Inc Live Price Chart